Summary
Updated Aug 30, 2026
Jennifer K. Simpson is President and CEO, Director of Panbela Therapeutics, Inc. (PBLA). 1 SEC Form 4 filing on record, dated 3 October 2024.
Trading Pattern
InsiderAlpha's records for Jennifer K. Simpson go back to 2024: 1 primary Form 4 filing, an average of 0.3 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who have reported open-market trades at the same companies as Jennifer K. Simpson. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Nant Capital, LLC - of PBLA open-market activity on record
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Jennifer K. Simpson?
Jennifer K. Simpson is a corporate insider, tracked as President and CEO, Director of Panbela Therapeutics, Inc. (PBLA). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Jennifer K. Simpson last file a Form 4?
The only primary Form 4 on record is dated 3 October 2024.
Where can I see all of Jennifer K. Simpson's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Jennifer K. Simpson and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial